Anish Bhatnagar - Jan 4, 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role: Chief Executive Officer, Director
Signature: /s/ Anish Bhatnagar
Stock symbol: SLNO
Transactions as of: Jan 4, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/8/2024, 05:34 PM
Previous filing: Dec 13, 2023
Next filing: Jan 29, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLNO	Common Stock	Award	$0	+150K	+617.36%	$0.00	174K	Jan 4, 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLNO	Employee stock option (right to buy)	Award	$0	+100K		$0.00	100K	Jan 4, 2024	Common Stock	100K	$36.70	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 25% of RSUs shall vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
F2	Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3	50% of the shares subject to the option shall vest on January 1, 2025 and one-twenty-fourth of the remaining shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.